Metformin, a common diabetes drug, shows promise in enhancing lung cancer treatment for overweight patients, according to new research. The study reveals that metformin boosts the effects of ...

Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer if those patients ...

A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and ...

Metformin use was associated with longer overall survival in a cohort of patients with non-small cell lung cancer and the subgroup of patients with a BMI ... in overweight NSCLC patients treated with ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

Regulators are reviewing what could become a multi-billion-dollar drug.

For our obesity program, as announced last week, we achieved alignment with the FDA at our recent end of Phase 2 meeting on a comprehensive Phase 3 registration program designed to leverage the ...

1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts. 2Department of Immunology, Harvard Medical School, Boston, Massachusetts. 3Department of Neurology, ...

Get detailed information on Pembrolizumab, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Checkpoint inhibitors are a type of immunotherapy that treats cancer by releasing the brakes on immune cells, so they are unleashed to attack cancer cells. Currently, all approved checkpoint ...

“As the metabolic landscape continues to evolve, we believe that the ability of a drug to address both obesity and its underlying comorbidities will become increasingly important, and we are ...